Search Results 231-240 of 16279 for monoclonal antibody
Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...
ADC biology. One promising novel therapeutic approach uses antibody-drug conjugates (ADC). ADCs combine monoclonal antibodies and cytotoxic payloads to target ...
... monoclonal antibody, to decrease dose-reducing toxicities. In the phase 1 trial, researchers observed reduced markers of toxicities and no new safety issues ...
SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...
DeSimone, M.D.. Antibody testing shows whether you have antibodies to the virus that causes COVID-19, also called coronavirus disease 2019. Having antibodies ...
The HER2 protein is produced by some breast tumors. Pertuzumab is a monoclonal antibody that interferes with the growth of this protein, which is eventually ...
I found similar results depleting a specific receptor involved in the apoptotic pathway. I also found tumor cells pre-treated with a monoclonal antibody, ...
Tislelizumab-jsgr is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...
Monoclonal antibodies, such as nivolumab, may block tumor growth in different ... History of severe hypersensitivity reaction to any monoclonal antibody ...
Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.